Established during 2000, the Nebraska Center for Virology (NCV;P20RR015635) is a multi-institutional, interdisciplinary center linking the virology expertise and resources at Nebraska's major biomedical research institutions: the University of Nebraska-Lincoln, the University of Nebraska Medical Center, and Creighton University. NCV investigators study human, animal, and plant viruses;their collective expertise presents a national strength and an exceptional opportunity to collaborate on model systems expected to lead to new approaches to understand and treat diseases threatening human health and economic well-being. Following nine years of COBRE program support, the NCV is developing a global research and training presence, and establishing an interdisciplinary research program addressing fundamental questions about infectious agents and their host interactions and creating an environment that is producing a new generation of innovative researchers with a broad knowledge of virology. COBRE support has allowed the Center to establish a critical mass of focused virology expertise and resources on each participating campus;however, to become an independent center, the NCV must bolster its interdisciplinary and cross-campus collaborations and implement a sustainability plan for its core facilities. In addition, several promising junior faculty conducting highly meritorious research continue to need NCV support and mentoring to gain independence. Additional capacity built through Phase III COBRE funding will enable the NCV to realize its strategic plan and achieve its long-term vision: to become an internationally recognized center of research excellence, with outstanding core facilities that serve IDeA, regional, and international scientific communities. This vision will be realized by completing three specific aims: 1) increase the research productivity and external funding potential of NCV faculty by continuing an effective mentoring program for junior faculty, sponsoring a pilot project program, and continuing support for four essential core facilities (administrative, flow cytometry, microscopy, and proteomics);2) strengthen the NCV's focus on translational research and virology research training and education through new partnerships and programs to share viral immunology and molecular virology expertise and scientific resources with researchers, clinicians, and students globally;and 3) emerge from COBRE Phase III funding as a self-sustaining center of research excellence in virology by diversifying the NCV's external research funding portfolio through increased individual-investigator and collaborative grant productivity.

Public Health Relevance

Phase III COBRE funding will ideally position the Nebraska Center for Virology to provide the infrastructure support needed to increase understanding of the molecular mechanisms by which different viral agents establish persistent infection, interact with the host, are transmitted from one host to another, and cause disease - with the ultimate goal of contributing to new strategies to treat and prevent such infections.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-2 (01))
Program Officer
Liu, Yanping
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Nebraska Lincoln
Schools of Arts and Sciences
United States
Zip Code
Ngalamika, Owen; Minhas, Veenu; Wood, Charles (2015) Kaposi's sarcoma at the University Teaching Hospital, Lusaka, Zambia in the antiretroviral therapy era. Int J Cancer 136:1241-2
Zhang, Tiejun; Yang, Ying; Yu, Feng et al. (2014) Kaposi`s sarcoma associated herpesvirus infection among female sex workers and general population women in Shanghai, China: a cross-sectional study. BMC Infect Dis 14:58
Zhang, Zhaojie; Xia, Yao; Lu, Yi et al. (2014) Prediction of H7N9 epidemic in China. Chin Med J (Engl) 127:254-60
Wang, Nanxi; Li, Yue; Niu, Wei et al. (2014) Construction of a live-attenuated HIV-1 vaccine through genetic code expansion. Angew Chem Int Ed Engl 53:4867-71
Gong, Lili; Ji, Wei-Ke; Hu, Xiao-Hui et al. (2014) Sumoylation differentially regulates Sp1 to control cell differentiation. Proc Natl Acad Sci U S A 111:5574-9
Workman, Aspen M; Jacobs, Ashley K; Vogel, Alexander J et al. (2014) Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells. PLoS One 9:e89010
Das, Anshuman; Dinh, Phat X; Panda, Debasis et al. (2014) Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication. J Virol 88:3103-13
Cao, Y; Minhas, V; Tan, X et al. (2014) High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China. Clin Microbiol Infect 20:475-81
Moore, Tyler C; Kumm, Phyllis M; Brown, Deborah M et al. (2014) Interferon response factor 3 is crucial to poly-I:C induced NK cell activity and control of B16 melanoma growth. Cancer Lett 346:122-8
Bihmidine, Saadia; Cao, Mingxia; Kang, Ming et al. (2014) Expression of Chlorovirus MT325 aquaglyceroporin (aqpv1) in tobacco and its role in mitigating drought stress. Planta 240:209-21

Showing the most recent 10 out of 42 publications